Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population-Reference-Cited by-同舟云学术

Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population

Published:2017-07-12 Issue:6 Volume:57 Page:2113-2121
ISSN:1436-6207
Container-title:European Journal of Nutrition
language:en
Short-container-title:Eur J Nutr

Author:

Meng Ge,Zhang Bo,Yu Fei,Li Chunlei,Zhang Qing,Liu Li,Wu Hongmei,Xia Yang,Bao Xue,Shi Hongbin,Su Qian,Gu Yeqing,Fang Liyun,Yang Huijun,Yu Bin,Sun Shaomei,Wang Xing,Zhou Ming,Jia Qiyu,Jiao Huanli,Wang Bangmao,Guo Qi,Carvalhoa Livia A.,Sun Zhong,Song Kun,Yu Ming,Niu Kaijun

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://link.springer.com/article/10.1007/s00394-017-1485-0/fulltext.html

Reference42 articles.

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J M 346:1221–1231

2. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285

3. Abd El-Kader SM, El-Den Ashmawy EM (2015) Non-alcoholic fatty liver disease: the diagnosis and management. World J Hepatol 7:846–858

4. Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5:1544–1560

5. Zampino R, Coppola N, Cirillo G, Boemio A, Pisaturo M, Marrone A, Macera M, Sagnelli E, Perrone L, Adinolfi LE, Miraglia del Giudice E (2013) Abdominal fat interacts with PNPLA3 I148 M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. J Viral Hepat 20:517–523

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06

2. Current Treatment Options, Including Diet, Exercise, and Medications;Clinics in Liver Disease;2023-05

3. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease;Hepatology;2023-03-17

4. Knowledge, Attitude, and Practices of Soft Drinks and its association with gender among Nursing Students, Karachi, Pakistan;Pakistan Journal of Health Sciences;2023-02-28

5. Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases;Clinical and Molecular Hepatology;2023-01-01